Nelson, Peter T.
Lee, Edward B.
Cykowski, Matthew D.
Alafuzoff, Irina
Arfanakis, Konstantinos
Attems, Johannes
Brayne, Carol
Corrada, Maria M.
Dugger, Brittany N.
Flanagan, Margaret E.
Ghetti, Bernardino
Grinberg, Lea T.
Grossman, Murray
Grothe, Michel J.
Halliday, Glenda M.
Hasegawa, Masato
Hokkanen, Suvi R. K.
Hunter, Sally
Jellinger, Kurt
Kawas, Claudia H.
Keene, C. Dirk
Kouri, Naomi
Kovacs, Gabor G.
Leverenz, James B.
Latimer, Caitlin S.
Mackenzie, Ian R.
Mao, Qinwen
McAleese, Kirsty E.
Merrick, Richard
Montine, Thomas J.
Murray, Melissa E.
Myllykangas, Liisa
Nag, Sukriti
Neltner, Janna H.
Newell, Kathy L.
Rissman, Robert A.
Saito, Yuko
Sajjadi, S. Ahmad
Schwetye, Katherine E.
Teich, Andrew F.
Thal, Dietmar R.
Tomé, Sandra O.
Troncoso, Juan C.
Wang, Shih-Hsiu J.
White, Charles L. III
Wisniewski, Thomas
Yang, Hyun-Sik
Schneider, Julie A.
Dickson, Dennis W.
Neumann, Manuela
Article History
Received: 18 October 2022
Revised: 21 November 2022
Accepted: 22 November 2022
First Online: 13 December 2022
Declarations
:
: E.B.L., D.W.D., M.N., D.R.T., G.H., G.G.K., and P.T.N. are members of the Editorial Board of <i>Acta Neuropathologica</i> and J.A. is the Editor-in-Chief of <i>Acta Neuropathologica</i>, but none of the coauthors were involved in the Editorial handling if this article. D.R.T. received speaker honorary from Novartis Pharma AG (Switzerland) and Biogen (USA), travel reimbursement from GE-Healthcare (UK) and UCB (Belgium), and collaborated with Novartis Pharma AG (Switzerland), Probiodrug (Germany), GE-Healthcare (UK), and Janssen Pharmaceutical Companies (Belgium).